ClinicalTrials.gg
RecruitingNCT07827898Updated Sep 18, 2026

Central Sensitization and Ultrasound in Lateral Epicondylitis

An observational study in Lateral Epicondylitis and Central Sensitization, sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Observational

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
128
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Lateral epicondylitis (LE) is a common musculoskeletal disorder characterized by pain and tenderness over the lateral elbow and may become chronic despite conservative treatment. Although LE is primarily associated with local tendon pathology, central sensitization, radial nerve involvement, and psychosocial factors may contribute to persistent pain and disability. This cross-sectional case-control study aims primarily to compare remote pressure pain thresholds between individuals with chronic LE and healthy controls. Secondary objectives are to compare clinical, functional, psychosocial, and ultrasonographic findings between the groups and to investigate the factors associated with functional impairment in individuals with chronic LE.

Read the detailed description

Lateral epicondylitis (LE), commonly known as tennis elbow, is a prevalent musculoskeletal disorder characterized by pain and tenderness over the lateral epicondyle. It is generally associated with repetitive mechanical loading, microtrauma, and degenerative changes affecting the common extensor tendon origin. Because LE may impair upper-extremity function, daily activities, and work productivity, it represents an important clinical and socioeconomic problem. Although conservative treatment is generally effective, symptoms may persist or become chronic in some individuals.The pathophysiology of chronic LE may extend beyond local tendon pathology. Emerging evidence suggests that altered nociceptive processing and central sensitization may contribute to persistent pain. Pressure pain threshold (PPT) assessment at both local and remote sites may help identify localized and widespread pressure pain hypersensitivity. The radial nerve may also be relevant because radial nerve entrapment and LE can produce overlapping clinical findings and may coexist. Ultrasonographic evaluation of both the common extensor tendon and radial nerve may therefore provide additional information about the peripheral components of the condition.

Psychosocial factors, including pain catastrophizing, kinesiophobia, depressive symptoms, and anxiety, may also influence pain severity, functional impairment, and the development or maintenance of sensitization. Although these factors have been extensively investigated in chronic musculoskeletal pain, their combined relationships with pain sensitivity, functional status, and ultrasonographic findings in chronic LE remain insufficiently characterized.

The primary objective of this cross-sectional case-control study is to compare remote PPT values between individuals with chronic LE and healthy controls. The secondary objectives are to compare local PPT, central sensitization, pain catastrophizing, kinesiophobia, depression, anxiety, functional status, radial nerve cross-sectional area, and common extensor tendon thickness between the groups. In the patient group, the study will also examine the relationships of functional status with local and remote PPT values, central sensitization, psychosocial factors, and ultrasonographic findings.

02

Conditions studied

  • Lateral Epicondylitis
  • Central Sensitization

Browse trials for

Keywords

  • lateral epicondylitis
  • central sensitization
  • radial nerve
03

In context

Tennis Elbow

296 studies on the registry are indexed under Tennis Elbow; 64 are open to participants now.

This study's planned enrollment of 128 is above the median of 90 across 29 observational studies indexed under Tennis Elbow.

Browse Tennis Elbow studies →

Lead sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey is the lead sponsor of 108 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients applying to the Physical Medicine and Rehabilitation outpatient clinic of Derince Training and Research Hospital and the Physical Medicine and Rehabilitation outpatient clinic of Sultan Abdulhamid Han Training and Research Hospital will be evaluated. Those who volunteer to participate in the study and meet the inclusion criteria will have their measurements and surveys completed at Sultan Abdulhamid Han Training and Research Hospital.

Eligibility criteria

  1. CASE GROUP

    Inclusion Criteria:

    Have unilateral lateral elbow pain persisting for at least 3 months Have a visual analog scale score of 4/10 or higher Have tenderness upon palpation of the common extensor tendon and/or lateral epicondyle region Experience elbow pain that occurs or worsens with hand grip or lateral elbow pain that occurs with resistant static contraction or stretching of the wrist extensors Have read and signed the volunteer consent form (VCF)

    Exclusion Criteria:

    • Having undergone surgery on the upper extremity or cervical region before
    • Presence of cervical or shoulder pathology
    • Mechanical symptoms in the elbow (locking, limited range of motion) and other elbow pathologies
    • History of trauma to the elbow
    • Presence of upper extremity neurological deficit
    • History of fibromyalgia, central nervous system disease, or rheumatic disease
    • Last 1 month history of physical therapy or injection for lateral epicondylitis
    • Pregnancy
  2. HEALTHY GROUP

Inclusion Criteria:

  • Not having experienced elbow pain before
  • Having read and signed the volunteer agreement form (BGOF)

    2.Exclusion criteria

  • Presence of upper extremity, shoulder, or neck pain within the last year
  • History of upper extremity fractures
  • Presence of neurological deficits
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
128 participants (estimated)
Patient registry
No

Groups and cohorts

  • lateral epicondylitis

    individuals with lateral epicondylitis

    Other: Pressure pain threshold · Other: Ultrasonography

  • Control Group

    Healthy people

    Other: Pressure pain threshold · Other: Ultrasonography

Interventions

  • OtherPressure pain threshold

    Pressure pain threshold is defined as the minimal pressure level that causes pain. The measurement will be applied twice for each region with a 1-minute interval, and the average of these applications will be recorded. A trial test will be conducted on the patient before the actual test. Pressure will be applied to selected points with a pressure algometer until pain is induced, and the test for that area will be terminated when the patient feels pain.

    Also known as: evaluation of pain threshold with a pressure pain algometer

  • OtherUltrasonography

    The cross-sectional area of the radial nerve will be measured in the antecubital fossa and the spiral groove. Three measurements will be taken for the nerve cross-sectional area, and the average will be calculated. For the measurement of common extensor tendon thickness, the probe will be placed over the lateral epicondyle, and the evaluation will be conducted with the elbow in 90 degrees of flexion and the forearm in mid-supination. The Sonosite M-Turbo device will be used for ultrasonography and will be performed by a rehabilitation specialist with 10 years of experience.

    Also known as: ultrasonographic evaluation

06

What researchers measure

Primary outcomes

  1. Pressure Pain Threshold (PPT)

    The pressure pain threshold is defined as the lowest pressure level that causes pain. The measurement will be taken from the anterior-medial region of the tibia (a distant, painless, and irrelevant area) using a Wagner manual pressure algometer (1 cm² probe-10 kg/20 lb). The measurement will be applied twice at 1-minute intervals, and the average of these applications will be recorded. A trial test will be conducted on the patient before the actual test. Pressure will be applied to the selected points with a pressure algometer until pain is induced, and the test in that area will be terminated when the patient feels pain.

    Time frame: Baseline

Secondary outcomes

  1. Central Sensitization Inventory

    CSI scores range from 0-100, with higher scores indicating greater severity of central sensitization-related symptoms.

    Time frame: Baseline

  2. Tampa Scale for Kinesiophobia (TSK)

    The TSK consists of a total of 17 items, and individuals evaluate each item using a 4-point Likert scale (1=strongly disagree, 4=strongly agree). The total score obtained from the scale reflects the individual's level of kinesiophobia. Increasing TSK scores indicate an increase in avoidance behaviors and fear related to pain.

    Time frame: Baseline

  3. Pain Catastrophizing Scale (PCS)

    The PCS consists of a total of 13 items, and each item is evaluated on a 5-point Likert scale (0=never, 4=always). The total and subscale scores obtained from the scale reflect the individual's level of catastrophic thinking toward pain. High PCS scores indicate an increase in negative cognitive and emotional responses to pain.

    Time frame: Baseline

  4. Patient-Rated Tennis Elbow Evaluation

    To evaluate upper extremity functionality, it is a questionnaire specifically designed for patients with lateral epicondylitis, providing patient follow-up and being condition-specific, with scoring ranging from 0 (no pain/disability) to 100 (possible worst pain and disability), and containing pain and function sub-scales. The total score is calculated out of 100 by summing the pain and function subscales. Low scores indicate better function.

    Time frame: Baseline

  5. Hospital Anxiety and Depression Scale

    It is a 14-item self-report scale that quickly, reliably, and independently of medical conditions assesses patients' anxiety and depression symptoms over the past week.

    Time frame: Baseline

  6. short form-12

    The health-related quality of life of the participants will be evaluated using the Short Form-12 (SF-12) Quality of Life Scale. SF-12 is a 12-item self-report scale that assesses individuals' physical function, physical role limitations, pain, general health perception, vitality, social function, emotional role limitations, and mental health status over the past four weeks. From the scale, the physical component score (Physical Component Summary, PCS) and the mental component score (Mental Component Summary, MCS) are obtained.

    Time frame: Baseline

  7. Pressure Pain Threshold - Local

    Pressure pain threshold is defined as the minimal pressure level that causes pain. The measurement will be applied twice for each region with a 1-minute interval, and the average of these applications will be recorded. A trial test will be conducted on the patient before the actual test. Pressure will be applied to the selected point with a pressure algometer until pain is induced, and the test for that area will be terminated when the patient feels pain. The measurement will be taken from the symptomatic common extensor tendon area, and a Wagner manual pressure algometer (1 cm² probe-10 kg/20 lb) will be used.

    Time frame: Baseline

  8. Radial Nerve CSA (in spiral groove and antecubital fossa)

    The cross-sectional area of the radial nerve will be measured in the antecubital fossa and spiral groove. In the spiral groove, the measurement will be taken with the patient's arm resting on the table, the elbow bent at 90°, the forearm in a pronation position, and the hand loosely resting on the table, with the probe perpendicular to the arm axis and placed on the lateral side of the distal third of the humerus. If measuring from the antecubital fossa, the patient will have their arm resting on the table, elbow extended, and forearm in a supine position; the probe will be placed transversely to the arm axis at the front of the elbow flexion, observing the elbow joint space. The radial nerve, located between the brachioradialis muscle and the anterior brachialis muscle, will be visualized before it divides into two branches. Two measurements will be taken for the nerve cross-sectional area, and the average will be calculated.

    Time frame: Baseline

  9. Common extansor tendon thickness

    For the measurement of common extensor tendon thickness, the probe will be placed on the lateral epicondyle, and the evaluation will be conducted with the elbow in 90 degrees of flexion and the forearm in mid-supination. To determine the evaluation point, a horizontal line of 1 cm will be placed from the upper edge of the lateral epicondyle. At this point, a vertical line will be drawn from the upper edge of the tendon tissue to the hyperechoic line of the humerus for measurement. The Sonosite M-Turbo device will be used for ultrasonography and it will be performed by a physical therapy and rehabilitation specialist with 10 years of experience.

    Time frame: Baseline

  10. Grip Strength Measurement

    It will be measured using a modified sphygmomanometer test (MST). a manual aneroid sphygmomanometer (gauge manometer + inflation bulb + cuff) will be used. First, the blood pressure measurement device will be transformed into a cylinder that the patient can comfortably grasp while resting. then the cuff will be inflated to 20 mmHg and the patient will apply maximum grip strength to the cuff. Grip measurements will be taken while the participant sits in a chair without armrests, with their feet supported, shoulders internally rotated, forearms in a neutral position, and elbows flexed at 90°. Before the assessment, information about the procedures and a trial will be conducted. They will be instructed to perform maximum isometric contraction for 5 seconds, and the highest force value (mmHg) will be recorded. The measurement will be taken 3 times with a 15-second rest interval, and the average will be calculated.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Keating C, Puentedura E, Lucado A, Cleland J. Exploring the Relationship Between Central Sensitization, Pain Characteristics, and Function in a Cross-Sectional Study of Individuals With Lateral Elbow Tendinopathy. Clin J Pain. 2026 Jan 1;42(1):e1335. doi: 10.1097/AJP.0000000000001335. PubMed 41084876 ↗
  • Abhimanyu V, Ritika P, Osama N, Srishti N, Gita H. Lateral epicondylitis: Are we missing out on radial nerve involvement? A cross-sectional study. J Bodyw Mov Ther. 2021 Jul;27:352-357. doi: 10.1016/j.jbmt.2021.01.014. Epub 2021 Jan 28. PubMed 34391257 ↗
  • Cancela-Cilleruelo I, Rodriguez-Jimenez J, Fernandez-de-Las-Penas C, Cleland JA, Arias-Buria JL. Pressure Pain Hypersensitivity and Ultrasound Changes in the Radial Nerve in Patients with Unilateral Lateral Epicondylalgia: A Case-Control Study. Diagnostics (Basel). 2023 Jul 26;13(15):2488. doi: 10.3390/diagnostics13152488. PubMed 37568851 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07827898
Responsible party
Sponsor
First posted
Sep 18, 2026
Start date
Aug 15, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Sep 18, 2026

Study contacts

Mustafa Hüseyin Temel, Assoc. Prof.
Contact
mhuseyintemel@gmail.com
2165422000 ext. +90
Mustafa Hüseyin Temel, Assoc. Prof.
principal investigator · Saglik Bilimleri Universitesi

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion